BCM
CORT icon

Brown Capital Management’s Corcept Therapeutics CORT Stock Holding History

Brown Capital Management’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.31M Sell
84,041
-9,652
-10% -$583K 1.46% 23
2026
Q1 		$3.78M Sell
93,693
-44,498
-32% -$1.66M 0.54% 44
2025
Q4 		$4.81M Sell
138,191
-101,856
-42% -$8M 0.39% 47
2025
Q3 		$20M Buy
+240,047
New +$17.4M 0.82% 38

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Brown Capital Management's CORT Position: Q2 2026 in Review

Brown Capital Management reduced its Corcept Therapeutics (CORT) stake by 10% in Q2 2026, selling an estimated $583K and leaving 84,041 shares worth $7.31M. The position accounts for 1.46% of the portfolio, ranked #23.

Brown Capital Management first reported a position in CORT in Q3 2025 and has held it in 4 quarters since. The position peaked at $20M in Q3 2025. 422 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Brown Capital Management held 84,041 shares of Corcept Therapeutics worth $7.31M as of Q2 2026.
  • Brown Capital Management sold 9,652 Corcept Therapeutics shares in Q2 2026, an estimated $583K.
  • Corcept Therapeutics made up 1.46% of Brown Capital Management's portfolio in Q2 2026, its #23 holding.
  • Brown Capital Management first reported a position in Corcept Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • Brown Capital Management's Corcept Therapeutics position peaked at $20M in Q3 2025.
  • 422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Brown Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.